Purpose: Present a case of Mirvetuximab soravtansine (MIRV)-induced intraepithelial corneal deposits, review a proposed mechanism to explain the blurred vision our patient experienced, and explain clinical exams that may be used to support the diagnosis.
Observations: A 63-year-old female with metastatic ovarian cancer diagnosed with intraepithelial corneal deposits two weeks after her first MIRV infusion. Treatment with topical prednisolone acetate 1 % ophthalmic suspension and lubricating eye drops without interruption of her MIRV infusions resulted in complete resolution of blurry vision and corneal deposits.
Conclusions And Importance: The natural reversibility of MIRV-induced keratopathies underscores the need for prompt and regular ophthalmic assessments throughout drug administration. Understanding the mechanism behind these corneal changes, how to recognize them in a clinical setting, and expedite their reversal are essential to improve quality-of-life metrics in patients receiving MIRV transfusions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869836 | PMC |
http://dx.doi.org/10.1016/j.ajoc.2025.102271 | DOI Listing |
Microsc Res Tech
March 2025
Department of Anatomy and Embryology, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
The eye of the laughing dove (Spilopelia senegalensis) is uniquely adapted to thrive in arid environments, withstanding airborne particles and harsh conditions, demonstrating its remarkable structural and functional resilience. This study aimed to explore the cellular composition of the laughing dove's cornea, focusing on telocytes-a cell type previously unreported in avian corneas. This work represents the first demonstration of telocytes in the cornea of any bird species.
View Article and Find Full Text PDFAm J Ophthalmol Case Rep
June 2025
Parker Cornea, 745 Corporate Woods Dr, Vestavia Hills, AL, 35242, USA.
Purpose: Present a case of Mirvetuximab soravtansine (MIRV)-induced intraepithelial corneal deposits, review a proposed mechanism to explain the blurred vision our patient experienced, and explain clinical exams that may be used to support the diagnosis.
Observations: A 63-year-old female with metastatic ovarian cancer diagnosed with intraepithelial corneal deposits two weeks after her first MIRV infusion. Treatment with topical prednisolone acetate 1 % ophthalmic suspension and lubricating eye drops without interruption of her MIRV infusions resulted in complete resolution of blurry vision and corneal deposits.
J Clin Med
January 2025
Centro de Oftalmología Barraquer, 08021 Barcelona, Spain.
to report a novel KRT3 Meesmann corneal dystrophy (MECD) mutation and its clinical findings in a Spanish family, thus completing the international database. Case series study. Two generations of three family members were studied.
View Article and Find Full Text PDFExp Eye Res
March 2025
Ege University, Faculty of Medicine, Department of Ophthalmology, Izmir, Turkey; Ege University, Faculty of Medicine, Ocular Surface Research Laboratory, Izmir, Turkey; LimbuStem R&D Medical Products Ltd., Ege University Technopark, Izmir, Turkey; Department of Stem Cell, Institute of Health Sciences, Ege University, Izmir, Turkey; Institute of Health Sciences, Department of Stem Cell, Ege University, Izmir, Turkey; Cord Blood Cell-Tissue Application and Research Center, Ege University, Izmir, Turkey. Electronic address:
The purpose of this study is to investigate the clinical and histopathological effectiveness of topical amniotic membrane extract (AME) applied at a clinically relevant dose in an experimental corneal alkaline burn model and to compare the results with amniotic membrane transplantation (AMT) as one of the most frequently used biologically based treatment options. To create an alkaline burn model, NaOH-impregnated filter paper was applied to all rabbits for 30 s. Rabbits were divided into 3 groups: Group 1 (n = 6): AME eye drop; Group 2 (n = 6): AMT; Group 3 (n = 4): control group.
View Article and Find Full Text PDFCornea
October 2024
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL.
Purpose: The purpose of this study was to report the management of chemoimmunotherapy-resistant ocular surface squamous neoplasia (OSSN) with iodine-125 (I-125) brachytherapy.
Methods: A 36-year-old man presented to the clinic with biopsy-proven OSSN that covered ∼70% of the corneal surface and extended to the 6 o'clock position of the inferior limbus of the OS. The visual acuity was 20/20 in the OD and 20/40 in the affected OS.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!